Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
Cell Reports - United States
doi 10.1016/j.celrep.2019.03.047
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV